arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Precigen, Inc.

PGEN Health Care Biotechnology: Pharmaceutical Preparations
$6.19
▼ -6.2% Today
as of Oct 23, 16:51 ET
Last 30 days -9.64% Sep 14 → Oct 23
$6.00 $6.69 $7.38 $8.06 $8.75 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$6.35
High
$6.38
Low
$6.15
Volume
$4M
Avg Vol
$5M
Mkt Cap
$2.9B
P/E (TTM)
—
Beta
—
52w High
$8.98
52w Low
$3.04
Div Yield
—
Shares Out
$358M

Recent Press Releases & News last 60 days · 21 items

Oct 20 · 02:13 Simply Wall St.
Precigen (PGEN) Stock May Be Fully Priced On Its Huge 3 Year Run
Oct 12 · 15:38 Insider Monkey
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Oct 5 · 14:44 Zacks
PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
▸ Show all 21 press releases & news Free account →

PGEN earnings at a glance

The options market is pricing a move of about ±10.2% after the report, a range of roughly $5.56 to $6.82 from today's $6.19. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.5% on average; after the most recent report on May 13, 2026 it moved +1.7%. That means options currently expect more movement than PGEN has typically delivered. PGEN beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 86%. The share price of $6.19 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.04
$8.98
53% of range
Avg surprise (last 4)
+7.4%
Avg reaction (last 2)
-1.7%
50% positive
Latest IV / EM
86%
EM ±10.2% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.23$-0.16$-0.09$-0.02$0.05 Actual $-0.10Actual $-0.08Actual $-0.08Actual $-0.10Actual $-0.23Actual $-0.09Actual $-0.07Est $-0.08Actual $-0.11Est $-0.14Actual $-0.11Est $-0.08Actual $-0.02Est $-0.03Actual $0.05 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-146M$-95M$-44M$7M$58M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.05 — — — — financials
Wed May 13, 2026Mar/2026 $-0.02 $-0.03 +33.3% +71.4% +1.7% earnings
Thu Nov 13, 2025Sep/2025 $-0.11 $-0.08 -37.5% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.11 $-0.14 +21.4% — — earnings
Wed May 14, 2025Mar/2025 $-0.07 $-0.08 +12.5% — -5.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.09 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.23 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.10 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.08 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.08 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.10 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$55M$23M——$856,000$1M——
Cost of revenue————————
Gross profit————————
Operating income$23M$-6M——$-32M$-23M——
Net income$20M$-8M—$-146M$-27M$-54M—$-24M
EPS (diluted)$0.05$-0.02—$-1.06$-0.09$-0.18—$-0.09

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$16M$7M$30M$14M$14M$6M$30M$25M
Inventory————————
Total current assets$134M$102M$115M$130M$63M$85M$102M$35M
Total assets$170M$139M$156M$171M$102M$129M$145M$83M
Long-term debt$94M$94M$93M$93M————
Total liabilities$127M$118M$135M$129M$108M$113M$79M$28M
Total equity$44M$20M$21M$42M$-37M$-14M$39M$55M

Implied volatility — last 90 days

32%115%198%280%363% Jun 07 — IV 50% · EM ±7.0%Jun 08 — IV 53% · EM ±7.0%Jun 09 — IV 33% · EM ±4.1%Jun 10 — IV 129% · EM ±15.3%Jun 11 — IV 89% · EM ±9.9%Jun 17 — IV 204% · EM ±8.5%Jun 19 — IV 75% · EM ±16.6%Jun 22 — IV 76% · EM ±15.8%Jun 23 — IV 84% · EM ±17.1%Jun 24 — IV 88% · EM ±17.6%Jun 25 — IV 91% · EM ±17.9%Jun 26 — IV 87% · EM ±16.6%Jun 29 — IV 92% · EM ±16.2%Jun 30 — IV 74% · EM ±12.7%Jul 01 — IV 91% · EM ±15.2%Jul 02 — IV 87% · EM ±14.1%Jul 03 — IV 91% · EM ±14.2%Jul 06 — IV 103% · EM ±14.3%Jul 07 — IV 109% · EM ±14.4%Jul 08 — IV 78% · EM ±9.8%Jul 09 — IV 77% · EM ±9.0%Jul 10 — IV 51% · EM ±5.6%Jul 13 — IV 104% · EM ±8.7%Jul 14 — IV 108% · EM ±7.8%Jul 15 — IV 364% · EM ±21.5%Jul 16 — IV 314% · EM ±13.1%Jul 20 — IV 83% · EM ±19.7%Jul 21 — IV 96% · EM ±22.3%Jul 22 — IV 101% · EM ±23.0%Jul 23 — IV 137% · EM ±30.8%Jul 24 — IV 124% · EM ±27.3%Jul 27 — IV 137% · EM ±28.6%Jul 28 — IV 136% · EM ±27.8%Jul 29 — IV 110% · EM ±22.0%Jul 30 — IV 139% · EM ±27.3%Jul 31 — IV 138% · EM ±26.3%Aug 03 — IV 201% · EM ±35.6%Aug 04 — IV 128% · EM ±22.0%Aug 05 — IV 93% · EM ±15.6%Aug 06 — IV 91% · EM ±14.7%Aug 07 — IV 82% · EM ±12.8%Aug 10 — IV 85% · EM ±11.8%Aug 11 — IV 108% · EM ±14.2%Aug 12 — IV 163% · EM ±20.4%Aug 13 — IV 162% · EM ±19.2%Aug 14 — IV 89% · EM ±9.8%Aug 17 — IV 236% · EM ±19.7%Aug 18 — IV 308% · EM ±22.3%Aug 19 — IV 271% · EM ±16.0%Aug 20 — IV 48% · EM ±2.0%Aug 24 — IV 68% · EM ±14.2%Aug 25 — IV 68% · EM ±14.0%Aug 26 — IV 65% · EM ±12.9%Aug 27 — IV 68% · EM ±13.4%Aug 28 — IV 49% · EM ±9.4%Aug 31 — IV 81% · EM ±14.4%Sep 01 — IV 70% · EM ±12.0%Sep 02 — IV 73% · EM ±12.1%Sep 03 — IV 58% · EM ±9.5%Sep 04 — IV 72% · EM ±11.3%Sep 07 — IV 81% · EM ±11.3%Sep 08 — IV 72% · EM ±9.5%Sep 09 — IV 53% · EM ±6.6%Sep 10 — IV 79% · EM ±9.4%Sep 11 — IV 46% · EM ±5.1%Sep 14 — IV 79% · EM ±6.6%Sep 15 — IV 69% · EM ±5.0%Sep 16 — IV 228% · EM ±13.5%Sep 17 — IV 167% · EM ±7.0%Sep 21 — IV 79% · EM ±16.6%Sep 22 — IV 79% · EM ±16.2%Sep 23 — IV 86% · EM ±17.1%Sep 24 — IV 93% · EM ±18.2%Sep 25 — IV 85% · EM ±16.3%Sep 28 — IV 72% · EM ±12.8%Sep 29 — IV 85% · EM ±14.6%Sep 30 — IV 89% · EM ±14.9%Oct 01 — IV 105% · EM ±17.0%Oct 02 — IV 75% · EM ±11.7%Oct 06 — IV 65% · EM ±8.6%Oct 07 — IV 80% · EM ±10.0%Oct 08 — IV 86% · EM ±10.2%

Sector peers

DYN
Dyne Therapeutics, Inc.
$3.0B $15.62-2.8%
ZLAB
Zai Lab Limited
$2.8B $24.03-0.7%
RCUS
Arcus Biosciences, Inc.
$3.1B $18.54-2.9%
ATAI
AtaiBeckley Inc.
$2.8B $7.350.0%
MBX
MBX Biosciences, Inc.
$2.6B $48.50-10.1%
KLRA
Kailera Therapeutics, Inc.
$2.4B $12.85-0.5%

PGEN earnings FAQ

What is PGEN's expected move for earnings?

Options currently price a move of about ±10.2%, or $0.63 per share either way from $6.19.

How does PGEN stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.5%, up 1 times and down 1 times.

What is PGEN's implied volatility?

PGEN's at-the-money implied volatility is about 86% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in